A recent study involving genetic regulation and pharmacological experiments in GLP-1R KO mice confirmed that GLP-1R signaling may be immunoregulatory, and that GLP-1R deficiency accelerates rejection reactions in a chronic heart transplant model induced by CTLA4-Ig (cytotoxic T lymphocyte-associated antigen-4) tolerance [16]
Safety Considerations and Side Effects Like all medications, GLP-1 drugs have potential side effects: Common side effects include: Nausea, vomiting, diarrhea (usually improving over time) Constipation Stomach pain or indigestion Injection site reactions (mild redness or itching) Less common but more serious concerns include: Pancreatitis (inflammation of the pancreas) Kidney problems Gastroparesis (stomach paralysis) in rare cases Joint and bone issues like arthritis and tendinitis Researchers found no established link between GLP-1 medications and pancreatitis, pancreatic cancer, or thyroid cancer in large studies with years of follow-up
10.1128/MCB.00157-14 126 TicklerA
At organism-interface sites, extracellular and membrane-proximal ROS shape host defense and vascular tone: in professional phagocytes, NOX2 assembles at the phagosomal membrane to generate large bursts of O 2 into the lumen, where rapid dismutation and the action of myeloperoxidase convert upstream oxidants into hypochlorous acid (HOCl), a potent microbicidal species that collaborates with proteases and pH control to sterilize engulfed targets (Nauseef 2019)
